Intra-Cellular Therapies' Reverse Merger Round

Intra-Cellular Therapies raised a round of funding on September 03, 2013. Investors include acquirer.

Intra-Cellular Therapies (ITI) is a biopharmaceutical company that is developing drugs for the treatment of diseases and disorders of the Central Nervous System (CNS). The Company develops compounds t…

Articles about Intra-Cellular Therapies' Reverse Merger Round: